Bolt Biotherapeutics Statistics
NASDAQ: BOLTHealthcareBiotechnologyUSD
3.65+0.05 (+1.39%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Bolt Biotherapeutics by the numbers
Bolt Biotherapeutics has a market capitalization of $7.0 million based on 1.93M shares outstanding. With trailing EPS of $-16.28, Bolt Biotherapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.4% below its 50-day average and 19.9% below its 200-day average.
Average daily trading volume is 26.26K shares, or about $95,838 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BOLT valuation vs. peer median
| Metric | BOLT | Peer median | Difference |
|---|---|---|---|
| Market cap | $7.03M | $6.80M | +3% |
| Avg. volume | 26.26K | 202.61K | -87% |
Peer median across 8 companies: ACXP, APRE, ENVB, NRSN, LEXX, AIM, XCUR, CELZ.
Valuation
- Market cap
- $7.03M
- EPS (TTM)
- $-16.28
- Shares outstanding
- 1.93M
Price and trading
- Previous close
- 3.60
- Open
- 3.55
- Day range
- 3.50 – 3.65
- 52-week range
- 3.10 – 7.20
- Beta
- —
- Volume
- 10.45K
- Average volume
- 26.26K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 14, 2025
Additional statistics
- Market Cap
- 7.03M
- Forward Pe
- -0.18
- Eps
- -16.28
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.20
- Week52 Low
- 3.10
- Avg Volume
- 26,257.00
- Shares Outstanding
- 1.93M
- Ma50
- 3.70
- Ma200
- 4.56
- Earnings Date
- Aug 14, 2025
- Pct From52w High
- -49.31%
- Pct From52w Low
- 17.74%